99% purity HGH Peptide (CJC-1295 NO DAC),CJC1295 Without DAC supplier, CJC-1295 Without DAC

Grundlegende Informationen:

Synonyme: CJC-1295 ohne DAC, CJC 1295 w/o DAC, MOD GRF 1-29, Neorelin, Modified Sermorelin
CAS NO.: 863288-34-0
Molekularformel: C152H252N44O42
Molekulargewicht: 3367.2
Molar Mass: 3368.7
Peptide purity: > 98.0%
Aussehen: White lyophilized powder
Verwandte Substanz: Total Impurities (%) ≤ 2.0%
Acetate content: ≤ 15.0%
Bacterial Endotoxins: ≤5 IU/mg
Sequence: Tyr-d-ALA-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Source: Chemical Synthesis
Reconstitution: To follow best practice guidelines for reconstituting CJC-1295 without DAC, reconstitute in sterile, bacteriostatic, distilled water, with light sonication if necessary.
Storage for MOD GRF 1-29: Lyophilized MOD GRF 1-29 is stable at room temperature for 90 Tage, however it should be stored in a freezer below -8°C for any extended period of time. After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C – 8° C. Store vials in an upright position. Store MOD GRF-129 refrigerated between temperatures 2°C – 8° C. Keep in the outer carton in order to protect from light. For one month can be stored at room temperature.
Haltbarkeit: One year from dispatch.

Descroption:

CJC-1295 ohne DAC (Mod GRF 1-29) (also referred to as simply Mod GRF) is an injectable peptide used to increase GH production. This peptide is a growth hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.
The principal use of CJC-1295 without DAC (Mod GRF 1-29) is to provide increased GH levels, which also results in increased IGF-1levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Allgemein, Mod GRF 1-29 is used as part of alternate plan to using GH, and only rarely is combined with GH.

The other principal GHRH product is CJC-1295. In almost all instances I recommend CJC-1295 without DAC (Mod GRF 1-29) over CJC-1295. The products differ in their duration of action. CJC-1295 ohne DAC (Mod GRF 1-29) has an approximately-ideal short duration of action allowing pulsatile dosing, whereas CJC-1295 has an extended duration of action preventing such dosing.

CJC-1295 ohne DAC (Mod GRF 1-29) generally is not used alone, but most commonly is used in combination with a peptide of the GHRP class, such as GHRP-2, GHRP-6, hexarelin, or ipamorelin.

Effects :

CJC-1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown potential to increase growth hormone and IGF-I secretion and effects, but it has been able to do so in very large amounts. CJC – 1295 Stimulates GH and IGF-1 Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis for more muscle growth.

• increases the secretion of growth hormone in the blood
• helps achieve significant muscle hardness
• promotes muscle growth and strength
• helps you effectively burn fat
• significantly improves the quality of skin, has a rejuvenating effect and smooths wrinkles
• Erhöht die Knochendichte
• effectively strengthens ligaments and joints
• has a significant positive effect on sleep, regeneration and vitality

How to use CJC 1295 without DAC :

Mod GRF 1-29 is typically manufactured as lyophilized (freeze-dried) powder in amounts of 2mg per vial.

This powder within the vial must be reconstituted with bacteriostatic water before injection, and promptly refrigerated after constitution and after each use due to its peptide nature.When reconstituting, typically 2ml of bacteriostatic water is gently mixed into the powder (normally an amount of 2mg of powder) which will then yield a Mod GRF 1-29 dose of 100mcg per 0.1ml (or 10iu on an insulin syringe).

Mod GRF 1-29 (CJC-1295 ohne DAC) can be administered subcutaneously (SQ) or intramuscularly (IM). There is not much difference between the two, with intramuscular seemingly resulting in a slightly quicker release from the injection site. The majority of individuals prefer to administer it subcutaneously for varying reasons, Jedoch.

Because GHRH analogues such as Mod GRF 1-29 (CJC-1295 ohne DAC) stimulate HGH release in a pulsatile manner, multiple Mod GRF 1-29 doses are required throughout the day that are typically administered on average 3 times daily spaced evenly apart. The most common protocol is as follows:

———————————————————————————————————————————————————————————————————————————————————————-

Kontaktieren Sie mich jetzt